PR+ breast cancer responds well to hormone therapy, underscoring the need for molecular insight and targeted treatment ...

ER+/PR+ breast cancer, common and hormone-responsive, offers a better prognosis and is key in treatment research advancements ...

By Kolade Adeyemo / Jambar Contributor Breast cancer is one of the most prevalent cancers worldwide, affecting millions of ...

HR+/HER2- breast cancer—or hormone receptor-positive, HER2-negative breast cancer—is the most common subtype of breast cancer. It makes up about 70% of all breast cancer cases. HR+/HER2- breast cancer ...

Medically reviewed by Archana Sharma, DO The exact cause or causes of triple-negative breast cancer are unknown, but ...

It would be short-sided, erroneous and dangerous to think ill of mifepristone, which has several important applications,, M.D ...

New postpartum depression findings could lead to a blood test to identify women at risk and possibly even to a preventive treatment. New postpartum depression research from the University of ...

At low doses it blocks the naturally occurring hormone progesterone from binding to its receptor in the body. This is one of the mechanisms by which it has been used in abortion care, as it blocks ...